Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1968 Aug;41(1):62–68.

Lysostaphin: an enzymatic approach to staphylococcal disease. 3. Combined lysostaphin-methicillin therapy of established staphylococcal abscesses in mice.

R E Dixon, J S Goodman, M G Koenig
PMCID: PMC2591441  PMID: 5683827

Full text

PDF
62

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BATTEN J. C., DINEEN P. A. P., MCCUNE R. M., Jr The effect of antimicrobial drugs on an experimental staphylococcal infection in mice. Ann N Y Acad Sci. 1956 Aug 31;65(3):91–102. doi: 10.1111/j.1749-6632.1956.tb36627.x. [DOI] [PubMed] [Google Scholar]
  2. BROWDER H. P., ZYGMUNT W. A., YOUNG J. R., TAVORMINA P. A. LYSOSTAPHIN: ENZYMATIC MODE OF ACTION. Biochem Biophys Res Commun. 1965 Apr 23;19:383–389. doi: 10.1016/0006-291x(65)90473-0. [DOI] [PubMed] [Google Scholar]
  3. LOURIA D. B., ROGERS D. E. An analysis of the effects of penicillin on an experimental infection produced by penicillin-resistant staphylococci. J Lab Clin Med. 1960 Feb;55:165–181. [PubMed] [Google Scholar]
  4. McCune R. DELIVERY OF ANTIMICROBIAL DRUGS ACROSS INFLAMMATORY MEMBRANE IN RABBITS. J Clin Invest. 1960 Jun;39(6):846–853. doi: 10.1172/JCI104105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McDERMOTT W. Microbial persistence. Yale J Biol Med. 1958 Feb;30(4):257–291. [PMC free article] [PubMed] [Google Scholar]
  6. ROGERS D. E. Observations on the nature of staphylococcal infections. Bull N Y Acad Med. 1959 Jan;35(1):25–38. [PMC free article] [PubMed] [Google Scholar]
  7. SCHINDLER C. A., SCHUHARDT V. T. PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS. Biochim Biophys Acta. 1965 Feb 15;97:242–250. doi: 10.1016/0304-4165(65)90088-7. [DOI] [PubMed] [Google Scholar]
  8. Schaffner W., Melly M. A., Hash J. H., Koenig M. G. Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies. Yale J Biol Med. 1967 Feb;39(4):215–229. [PMC free article] [PubMed] [Google Scholar]
  9. Schaffner W., Melly M. A., Koenig M. G. Lysostaphin: an enzymatic approach to staphylococcal disease. II. In vivo studies. Yale J Biol Med. 1967 Feb;39(4):230–244. [PMC free article] [PubMed] [Google Scholar]
  10. WERNER C. A., KNIGHT V., McDERMOTT W. Studies of microbial populations artificially localized in vivo. I. Multiplication of bacteria and distribution of drugs in agar loci. J Clin Invest. 1954 May;33(5):742–752. doi: 10.1172/JCI102943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zygmunt W. A., Browder H. P., Tavormina P. A. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus. Can J Microbiol. 1967 Jul;13(7):845–853. doi: 10.1139/m67-111. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES